Nikita Shah
Executive Vice President · 3 filings · Latest: Aug 12, 2026
Amneal Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMRX | Nikita Shah | Executive Vice President | Aug 12, 2026 | Sale | $17.51 | 146,403 | $2.6M | 253,390 | |
AMRX | NIKITA SHAH | — | Aug 12, 2026 | Proposed Sale | $17.47 | 146,403 | $2.6M | — | |
AMRX | Nikita Shah | Executive Vice President | Mar 4, 2026 | Option Exercise | — | 35,880 | — | 417,769 | |
AMRX | Nikita Shah | Executive Vice President | Mar 3, 2026 | Option Exercise | — | 472,619 | — | 565,742 | |
AMRX | NIKITA SHAH | — | Nov 12, 2025 | Proposed Sale | $11.92 | 131,856 | $1.6M | — | |
AMRX | Shah Nikita | — | Aug 22, 2025 | Proposed Sale | $9.70 | 36,796 | $356.9K | — | |
AMRX | Shah Nikita | — | Aug 22, 2025 | Proposed Sale | $9.75 | 84,036 | $818.9K | — | |
AMRX | Shah Nikita | — | Aug 14, 2025 | Proposed Sale | $9.25 | 71,694 | $663.1K | — | |
AMRX | Shah Nikita | — | Aug 12, 2025 | Proposed Sale | $9.06 | 50,000 | $453.0K | — | |
AMRX | Shah Nikita | — | May 16, 2025 | Proposed Sale | $7.50 | 49,140 | $368.6K | — |